| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | GDC-0941 | FIMM | pan-cancer | AAC | -0.0079 | 1 |
| mRNA | avicin D | CTRPv2 | pan-cancer | AAC | 0.0023 | 1 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.0013 | 1 |